Skip to content

EMDS N-Acetylprocainamide Calibrator #67635/95

by Em Diagnostic Systems, Inc.

510(k) K874101

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK874101 Date9 Nov 1987ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DLJ
Device Class
Class II
Regulation
21 CFR Part 862.3200
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a Calibrator, Drug Specific (product code DLJ), designed to standardize and verify the accuracy of analytical instruments measuring N-acetylprocainamide concentrations in clinical toxicology settings. It provides a reference standard for ensuring precise quantitative analysis of the drug in biological samples, supporting diagnostic accuracy in monitoring procainamide toxicity or therapeutic levels.

The calibrator is supplied as a non-sterile, single-use reagent intended for use in laboratory settings. It is regulated under 21 CFR 862.3200 and holds an FDA 510(k) clearance (K874101) as substantially equivalent to a predicate device, with a decision date of November 9, 1987. Storage conditions and handling instructions are not specified in the regulatory data, but it is classified as a Class II medical device under special controls for clinical toxicology applications.

Other devices from Em Diagnostic Systems, Inc.

See all devices from Em Diagnostic Systems, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the EMDS N-Acetylprocainamide Calibrator #67635/95 in a clinical setting?

    This calibrator is designed to standardize and verify the accuracy of analytical instruments that measure N-acetylprocainamide concentrations in biological samples. It ensures precise quantitative analysis, which is critical for monitoring procainamide toxicity or therapeutic drug levels in clinical toxicology settings.

  • Is this calibrator intended for single-use or repeated use in a laboratory?

    The EMDS N-Acetylprocainamide Calibrator #67635/95 is explicitly labeled as a single-use reagent, meaning it should not be reused after opening. This designation aligns with its role as a reference standard for one-time calibration or verification of analytical instruments.

  • How is this device regulated, and what does its classification mean for buyers?

    The device holds an FDA 510(k) clearance (K874101) under 21 CFR 862.3200, classifying it as a Class II medical device with special controls for clinical toxicology applications. This means it has undergone regulatory review for safety and effectiveness, ensuring it meets established performance standards for calibrating procainamide measurements.

  • Are there specific storage instructions provided for this calibrator?

    The provided regulatory data does not specify storage conditions or handling instructions for this calibrator. Buyers should consult the manufacturer’s labeling or instructions for proper storage (e.g., temperature, light exposure) to maintain its stability and accuracy before use.

  • What types of laboratories would benefit most from using this calibrator?

    This calibrator is specifically designed for clinical toxicology laboratories that analyze N-acetylprocainamide levels in patient samples. It is particularly useful in settings where precise drug monitoring is required—such as hospitals, poison control centers, or specialized toxicology labs—to ensure accurate diagnostic results for procainamide-related cases.